Louis Moore Bacon's GMAB Position Overview
Louis Moore Bacon (via Moore Capital Management, Lp) currently holds 420,487 shares of Genmab A/S (GMAB) worth $11.55 M, representing 0.17% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Louis Moore Bacon has initiated a new position in GMAB, representing a fresh investment thesis on this company. Largest addition occurred in Q2 2026, adding 208,782 shares.
Analysis based on 13F filings available since 2013 Q2
Louis Moore Bacon's Genmab A/S (GMAB) Holding Value Over Time
Track share changes against reported price movement
Quarterly Genmab A/S (GMAB) Trades by Louis Moore Bacon
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +208,782 | Add 98.62% | 420,487 | $27.47 |
| Q1 2026 | +211,705 | New Buy | 211,705 | $26.83 |
Louis Moore Bacon's Genmab A/S Investment FAQs
Louis Moore Bacon first purchased Genmab A/S (GMAB) in Q1 2026, acquiring 211,705 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon has held Genmab A/S (GMAB) for 2 quarters since Q1 2026.
Louis Moore Bacon's largest addition to Genmab A/S (GMAB) was in Q1 2026, adding 211,705 shares worth $5.68 M.
According to the latest 13F filing for Q2 2026, Louis Moore Bacon's firm, Moore Capital Management, Lp, owns 420,487 shares of Genmab A/S (GMAB), valued at approximately $11.55 M.
As of the Q2 2026 filing, Genmab A/S (GMAB) represents approximately 0.17% of Louis Moore Bacon's publicly disclosed stock portfolio, making it one of their key holdings.
Louis Moore Bacon's peak holding in Genmab A/S (GMAB) was 420,487 shares, as reported at the end of Q2 2026.